|1.||Bartfai, Tamas: 4 articles (06/2005 - 05/2002)|
|2.||Langel, Ulo: 4 articles (06/2005 - 05/2002)|
|3.||Bongianni, Fulvia: 1 article (12/2014)|
|4.||Pantaleo, Tito: 1 article (12/2014)|
|5.||Mutolo, Donatella: 1 article (12/2014)|
|6.||Cinelli, Elenia: 1 article (12/2014)|
|7.||McGowan, H W: 1 article (06/2014)|
|8.||Schuijers, J A: 1 article (06/2014)|
|9.||McDonald, A C: 1 article (06/2014)|
|10.||McDonald, S J: 1 article (06/2014)|
06/01/2005 - "Since its introduction in 2002, galnon has been characterized to inhibit seizures, decrease feeding behaviour, diminish physical signs of opiate withdrawal and to alleviate heat-hyperalgesic response to partial sciatic nerve injury. "
06/01/2005 - "Galnon is a non-peptide, systemically active galanin receptor agonist which has been tested in feeding, seizure and forced swim task in in vivo rodent experimental models. "
02/01/2004 - "Previous studies have shown that galnon acts as a systemically active, blood-brain barrier crossing agonist on galanin signaling both in vitro and in vivo, inhibiting pentylenetetrazole-induced seizures. "
05/14/2002 - "galnon reduced the severity and increased the latency of pentylenetetrazole-induced seizures in mice and reversed the proconvulsant effects of the galanin receptor antagonist M35, injected into a lateral ventricle. "
|2.||Post-Traumatic Stress Disorders (PTSD)
03/01/2009 - "This study examined the relationship between stress-induced posttraumatic stress disorder (PTSD)-like behavioral response patterns in rats and galanin mRNA levels in key brain areas and the effects of acute phase pharmacologic manipulation using an agonist (galnon) on behavioral, physiologic, and response patterns of brain-derived neurotrophic factor (BDNF) and 5-hydroxytryptamine-1A (5HT-1A). "
|3.||Substance-Related Disorders (Drug Abuse)
|4.||Wounds and Injuries (Trauma)
|5.||Status Epilepticus (Complex Partial Status Epilepticus)
|3.||Brain-Derived Neurotrophic Factor (BDNF)
|4.||Messenger RNA (mRNA)
|5.||Galanin Receptors (Galanin Receptor)
|6.||Type 1 Galanin Receptor
|7.||Citric Acid (Citrate)